Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.665 USD | -2.79% |
|
-13.97% | -11.47% |
07-01 | Relmada Therapeutics, Inc.(NasdaqGS:RLMD) added to Russell Microcap Growth Index | CI |
07-01 | Relmada Therapeutics, Inc.(NasdaqGS:RLMD) added to Russell 3000E Growth Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.47% | 114M | |
+19.96% | 126B | |
+23.27% | 118B | |
+23.26% | 27.87B | |
-18.44% | 20.95B | |
-15.13% | 16.92B | |
-13.53% | 16.18B | |
+10.10% | 14.84B | |
-46.10% | 14.79B | |
+51.90% | 14.08B |
- Stock Market
- Equities
- RLMD Stock
- News Relmada Therapeutics, Inc.
- Guggenheim Adjusts Price Target on Relmada Therapeutics to $60 From $50, Reiterates Buy Rating